Consonance Capital Management LP 13D and 13G filings for Assembly Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 2:45 pm Sale |
2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Consonance Capital Management LP | 0 0.000% |
-164,156![]() (Position Closed) |
Filing |
2021-02-17 3:07 pm Sale |
2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Consonance Capital Management LP | 164,156 5.970% |
-340,719![]() (-67.49%) |
Filing |
2021-02-16 4:18 pm Purchase |
2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Consonance Capital Management LP | 504,875 9.990% |
340,719![]() (+207.56%) |
Filing |
2021-02-16 2:38 pm Purchase |
2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Consonance Capital Management LP | 164,156 5.970% |
7,623![]() (+4.87%) |
Filing |